|
UTOMORohmad Yudi 研究業績一覧 (11件)
論文
-
岡田智,
Rohmad Yudi Utomo,
住吉晃,
青木伊知男,
中村浩之.
アミロイドβ線維化を検出・阻害するクルクミン誘導体MRIプローブの開発,
日本分子イメージング学会機関誌,
Vol. 16,
No. 1,
p. 26-29,
Jan. 2024.
-
R. Y. Utomo,
S. Okada,
A. Sumiyoshi,
I. Aoki,
H. Nakamura.
Development of an MRI contrast agent for both detection and inhibition of the amyloid-β fibrillation process,
RSC Adv.,
Feb. 2022.
-
R. Y. Utomo,
A. Sugie,
S. Okada,
K. Miura,
H. Nakamura.
Detoxification of amyloid β fibrils by curcumin derivatives and their verification in a Drosophila Alzheimer's model,
Chem. Commun.,
58,
2576-2579,
Jan. 2022.
-
R. Yudi Utomo,
Y. Asawa,
S. Okada,
A. Yoshimori,
J. Bajorath,
H. Nakamura.
Development of curcumin-based amyloid β aggregation inhibitors for Alzheimer's disease using the SAR matrix-approach,
The International Center for Chemical and Biological Sciences (ICCBS-2021),
Bioorg. Med. Chem.,
46,,
116357,
Feb. 2021.
国内会議発表 (査読なし・不明)
-
中村浩之,
Rohmad Yudi Utomo,
岡田智,
住吉晃,
青木 伊知男.
アミロイドβ繊維化を検出・阻害するMRIプローブの開発,
日本化学会第102春季年会,
Mar. 2022.
-
Rohmad Yudi Utomo,
杉江淳,
岡田智,
三浦一輝,
中村浩之.
Curcumin誘導体のアミロイドβ繊維の解離を介した解毒作用とショウジョウバエのアルツハイマー病モデルにおける検証,
日本薬学会142春季年会,
Mar. 2022.
-
Rohmad Yudi Utomo,
Yasunobu Asawa,
Atsushi Yoshimori,
Hiroyuki Nakamura.
Novel Curcumin Derivatives Generated from SAR Matrix Possess as Amyloid β Inhibitors for Alzheimer?s Disease,
第64回日本薬学会関東支部大会(オンライン),
Sept. 2020.
-
Rohmad Yudi Utomo,
Yasunobu Asawa,
Shinichi Sato,
Atsushi Yoshimori,
Hiroyuki Nakamura.
Novel Curcumin Derivatives Generated from SAR Matrix Possess as Amyloid β Inhibitors,
日本薬学会第140年会,
Mar. 2020.
学位論文
-
SAR Matrix-Assisted Design of Curcumin Derivatives as Amyloid β Inhibitors and Their Application to MRI Contrast Agents for Alzheimer’s Disease,
Summary,
Doctor (Science),
Tokyo Institute of Technology,
2022/03/26,
-
SAR Matrix-Assisted Design of Curcumin Derivatives as Amyloid β Inhibitors and Their Application to MRI Contrast Agents for Alzheimer’s Disease,
Thesis,
Doctor (Science),
Tokyo Institute of Technology,
2022/03/26,
-
SAR Matrix-Assisted Design of Curcumin Derivatives as Amyloid β Inhibitors and Their Application to MRI Contrast Agents for Alzheimer’s Disease,
Exam Summary,
Doctor (Science),
Tokyo Institute of Technology,
2022/03/26,
[ BibTeX 形式で保存 ]
[ 論文・著書をCSV形式で保存
]
[ 特許をCSV形式で保存
]
|